O'Reilly logo

Patently Innovative by R Bouchard

Stay ahead with the world's most comprehensive technology and business learning platform.

With Safari, you learn the way you learn best. Get unlimited access to videos, live online training, learning paths, books, tutorials, and more.

Start Free Trial

No credit card required

3

Empirical analysis of drug approval*

Abstract:

Canada’s proposed new drug regime, termed the ‘Progressive Licensing Framework’ (PLF), has received considerable attention over the last number of years. PFL is an example of ‘real-world’ or ‘lifecycle’-based models of drug development. On the one hand, its critics claim that ‘flexible departure,’ or expedited approval prior to completion of traditional Phase 3 clinical trials, may lead to a lower standard for drug approval and an increase in unsafe products on the market. Supporters, on the other hand, claim that more emphasis on post-market safety will effectively recalibrate the risks, benefits, and uncertainties of therapeutic product development. Here we develop a novel empirical method ...

With Safari, you learn the way you learn best. Get unlimited access to videos, live online training, learning paths, books, interactive tutorials, and more.

Start Free Trial

No credit card required